학술논문
Response to Letter to the Editor from Zandee and Links: 'Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for 131I Administration'
Document Type
Letter to the editor
Author
Source
Journal of the Endocrine Society. March 2023, Vol. 7 Issue 3
Subject
Language
English
ISSN
2472-1972
Abstract
In our view, there is little doubt that use of recombinant human thyrotropin (rhTSH) has proved of significant benefit to patients with low- or intermediate-risk differentiated thyroid cancer (DTC). And [...]